Target intelligence / Profile preview

Tungsten (W)

Target
W
Molecular classification
Chemical element, Transition metal, Enzyme cofactor
01

Overview

Tungsten is a transition metal (atomic symbol W, atomic number 74) that is not naturally found in human biological systems but is essential for certain microorganisms. In these organisms, it serves as a catalytic metal center in tungstoenzymes, such as formate dehydrogenase, which are involved in anaerobic metabolism [1][2]. In medical research, tungsten compounds like sodium tungstate have demonstrated insulin-mimetic properties, showing potential in treating diabetes and obesity by inhibiting protein tyrosine phosphatases and enhancing insulin signaling pathways [3][4]. However, tungsten is not a standard therapeutic target; it is a chemical element whose pharmacological use is limited by significant safety concerns. Chronic exposure to tungsten dust is associated with hard metal lung disease (a form of interstitial lung disease) and potential reproductive and developmental toxicity [5]. Consequently, while it exhibits interesting biochemical properties, it remains an experimental agent rather than a recognized drug target in human medicine.

Other names
WolframAtomic number 74W
02

Mechanism of action

Tungsten, primarily in the form of sodium tungstate, acts as an insulin-mimetic agent by inhibiting protein tyrosine phosphatases (PTPases). This inhibition leads to the sustained phosphorylation of the insulin receptor and its substrates, thereby activating downstream signaling pathways like the ERK1/2 and PI3K/Akt pathways, which promote glucose uptake and glycogen synthesis [3][4].

03

Biological functions

Enzyme cofactor in prokaryotes (e.g., formate dehydrogenase, carboxylic acid reductase) [1]Insulin-mimetic activity (experimental) [3]Inhibition of protein tyrosine phosphatases [4]
04

Disease associations

Diabetes mellitus (experimental treatment) [3]Obesity (experimental treatment) [4]Hard metal lung disease (occupational exposure) [5]Heavy metal toxicity
05

Safety considerations

Hard metal lung disease (interstitial fibrosis) [5]NephrotoxicityReproductive and developmental toxicityPotential carcinogenicity (when combined with cobalt)
06

Interacting drugs

Sodium tungstate (experimental compound)
07

Biomarkers

Urinary tungsten levelsBlood tungsten concentrationTungsten-to-creatinine ratio

Beyond the preview

Go deeper on Tungsten (W).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tungsten (W).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call